Purpose The optimal management of stage I follicular lymphoma, according to consensus
guidelines, is based on uncontrolled experiences of select institutions. Diverse treatment …

Purpose Advanced-stage follicular lymphoma is considered incurable. The pace of
improvements in treatment has been slow. This article analyzes five sequential cohorts of …

BACKGROUND Despite international practice guidelines endorsing radiotherapy (RT) as
the preferred initial therapy, treatment approaches vary for patients with early‐stage follicular …

Purpose Optimal therapy of follicular lymphoma (FL) is not defined. We analyzed a large
prospective cohort study to identify current demographics and patterns of care of FL in the …

Follicular lymphoma is a heterogeneous B-cell lymphoma both in presentation and at
progression. For most patients it is a chronic, relapsing indolent disease with overall survival …

Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …

Background The natural history of follicular lymphoma is believed not to have changed over
the last 30 years. Median survivals have ranged from 7 to 10 years, and the disease is …

For the majority of patients with newly diagnosed follicular lymphoma (FL), current
treatments, while not curative, allow for long remission durations. However, several …

Follicular lymphoma (FL) is the second most common lymphoma, and by virtue of its
chronicity, may be the most prevalent and most treated lymphoma in the United States …

Background A wait-and-see policy (WS) does not appear to modify the long-term prognosis
of advanced-stage follicular lymphomas (FL), while irradiation of limited stages some times …